Henk J. Out

Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies

Henk J. Out, C.D. Kooijman, Hein W. Bruinse et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 1991 · 278 citations

Medicine, Obstetrics, Pathology +16

A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization

Henk J. Out, Bernadette Mannaerts, Stefan Driessen et al. · Human Reproduction · 1995 · 214 citations

Medicine, Endocrinology, Gynecology +17

A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies

Henk J. Out, Hein W. Bruinse, G. C. M. L. Christiaens et al. · American Journal of Obstetrics and Gynecology · 1992 · 179 citations

Medicine, Gynecology, Obstetrics +17

Increasing the daily dose of recombinant follicle stimulating hormone (Puregon®) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation

Henk J. Out, D.D.M. Braat, Bea M.E. Lintsen et al. · Human Reproduction · 2000 · 102 citations

Medicine, Gynecology, Pharmacotherapy +17

Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial

Herjan J.T Coelingh Bennink, Bart C.J.M. Fauser, Henk J. Out · Fertility and Sterility · 1998 · 100 citations

Medicine, Endocrinology, Gynecology +13